Pre-conditioning with synthetic CpG-oligonucleotides attenuates myocardial ischemia/reperfusion injury via IL-10 up-regulation

Basic Research in Cardiology

Volumn 108, Issue 5, 2013, Pages

  Markowski, P ^a   Boehm, O ^a   Goelz, L ^b   Haesner, A L ^b   Ehrentraut, H ^a   Bauerfeld, K ^a   Tran, N ^c   Zacharowski, K ^c   Weisheit, C ^a   Langhoff, P ^a   Schwederski, M ^a   Hilbert, T ^a   Klaschik, S ^a   Hoeft, A ^a   Baumgarten, G ^a   Meyer, R ^b   Knuefermann, P ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

CpG ODN; Heart; IL 10; Ischemia reperfusion; Preconditioning; TLR9

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; PATTERN RECOGNITION RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION SIZE; HEART PROTECTION; INFLAMMATORY CELL; ISCHEMIC PRECONDITIONING; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; UPREGULATION; WILD TYPE;

EID: 84881082564     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-013-0376-7     Document Type: Article

References (48)

1. Albrecht M, Zitta K, Bein B, Wennemuth G, Broch O, Renner J, Schuett T, Lauer F, Maahs D, Hummitzsch L, Cremer J, Zacharowski K, Meybohm P (2013) Remote ischemic preconditioning regulates HIF-1α levels, apoptosis and inflammation in heart tissue of cardiosurgical patients: a pilot experimental study. Basic Res Cardiol 108:314. doi: 10.1007/s00395-012-0314-0
2. Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, Plonquet A, Gherardi RK, Chazaud B (2007) Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 204:1057-1069. doi: 10.1084/jem.20070075 (Pubitemid 46798150)
3. Bell R, Beeuwkes R, Botker HE, Davidson S, Downey J, Garcia-Dorado D, Hausenloy DJ, Heusch G, Ibanez B, Kitakaze M, Lecour S, Mentzer R, Miura T, Opie L, Ovize M, Ruiz-Meana M, Schulz R, Shannon R, Walker M, Vinten-Johansen J, Yellon D (2012) Trials, tribulations and speculation! Report from the 7th Biennial Hatter Cardiovascular Institute Workshop. Basic Res Cardiol 107:300. doi: 10.1007/s00395-012-0300-6
4. Bode C, Zhao G, Steinhagen F, Kinjo T, Klinman DM (2011) CpG DNA as a vaccine adjuvant. Expert Rev Vaccines 10:499-511. doi: 10.1586/erv.10.174
5. Cai ZP, Parajuli N, Zheng X, Becker L (2012) Remote ischemic preconditioning confers late protection against myocardial ischemia-reperfusion injury in mice by upregulating interleukin-10. Basic Res Cardiol 107:277. doi: 10.1007/s00395-012-0277-1
6. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, Miller-Graziano C, Moldawer LL, Mindrinos MN, Davis RW, Tompkins RG, Lowry SF (2005) A network-based analysis of systemic inflammation in humans. Nature 437:1032-1037. doi: 10.1038/nature03985 (Pubitemid 41486985)
7. Cao Z, Ren D, Ha T, Liu L, Wang X, Kalbfleisch J, Gao X, Kao R, Williams D, Li C (2012) CpG-ODN, the TLR9 agonist, attenuates myocardial ischemia/reperfusion injury: involving activation of PI3 K/Akt signaling. Biochim Biophys Acta 1832:96-104. doi: 10.1016/j.bbadis.2012.08.008
8. Chen CJ, Kono H, Golenbock D, Reed G, Akira S, Rock KL (2007) Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 13:851-856. doi: 10.1038/nm1603 (Pubitemid 47038190)
9. Dominguez-Rodriguez A, Abreu-Gonzalez P, de la Rosa A, Vargas M, Ferrer J, Garcia M (2005) Role of endogenous interleukin-10 production and lipid peroxidation in patients with acute myocardial infarction treated with primary percutaneous transluminal coronary angioplasty, interleukin-10 and primary angioplasty. Intern J Cardiol 99:77-81. doi: 10.1016/j.ijcard.2003.12.027 (Pubitemid 40261028)
10. Ehrentraut SF, Dörr A, Ehrentraut H, Lohner R, Lee SH, Hoeft A, Baumgarten G, Knuefermann P, Boehm O, Meyer R (2012) Vascular dysfunction following polymicrobial sepsis: role of pattern recognition receptors. PLoS ONE 7:e44531. doi: 10.1371/journal.pone.0044531
11. Eltzschig HK, Eckle T (2011) Ischemia and reperfusion - from mechanism to translation. Nat Med 17:1391-1401. doi: 10.1038/nm.2507
12. Frangogiannis NG (2012) Regulation of the inflammatory response in cardiac repair. Circ Res 110:159-173. doi: 10.1161/CIRCRESAHA.111.243162
13. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K (2010) Development of monocytes, macrophages, and dendritic cells. Science 327:656-661. doi: 10.1126/science.1178331
14. Gibbons RJ, Valeti US, Araoz PA, Jaffe AS (2004) The quantification of infarct size. J Am Coll Cardiol 44:1533-1542. doi: 10.1016/j.jacc.2004.06.071 (Pubitemid 39377707)
15. Ha T, Hu Y, Liu L, Lu C, McMullen JR, Kelley J, Kao RL, Williams DL, Gao X, Li C (2010) TLR2 ligands induce cardioprotection against ischaemia/ reperfusion injury through a PI3K/Akt-dependent mechanism. Cardiovasc Res 87:694-703. doi: 10.1093/cvr/cvq116
16. Ha T, Hua F, Liu X, Ma J, McMullen JR, Shioi T, Izumo S, Kelley J, Gao X, Browder W, Williams DL, Kao RL, Li C (2008) Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3 K/Akt-dependent mechanism. Cardiovasc Res 78:546-553. doi: 10.1093/cvr/cvn037 (Pubitemid 351769766)
17. Hausenloy DJ, Yellon DM (2011) The therapeutic potential of ischemic conditioning: an update. Nat Rev Cardiol 8:619-629. doi: 10.1038/nrcardio.2011. 85
18. Heusch G (2013) Cardioprotection: chances and challenges of its translation to the clinic. Lancet 381:166-175. doi: 10.1016/S0140-6736(12)60916- 7
19. Heusch G, Kleinbongard P, Skyschally A, Levkau B, Schulz R, Erbel R (2012) The coronary circulation in cardioprotection: more than just one confounder. Cardiovasc Res 94:237-245. doi: 10.1093/cvr/cvr271
20. Kannan Y, Yu J, Raices RM, Seshadri S, Wei M, Caligiuri MA, Wewers MD (2011) IκBζ augments IL-12- and IL-18-mediated IFNγ production in human NK cells. Blood 117:2855-2863. doi: 10.1182/blood-2010-07-294702
21. Khaliulin I, Clarke SJ, Lin H, Parker J, Suleiman MS, Halestrap AP (2007) Temperature preconditioning of isolated rat hearts - a potent cardioprotective mechanism involving a reduction in oxidative stress and inhibition of the mitochondrial permeability transition pore. J Physiol 581:1147-1161. doi: 10.1113/jphysiol.2007.130369 (Pubitemid 46887984)
22. Kim SC, Boehm O, Meyer R, Hoeft A, Knufermann P, Baumgarten G (2012) A murine closed-chest model of myocardial ischemia and reperfusion. J Vis Exp 65:e3896. doi: 10.3791/3896
23. Klaschik S, Tross D, Shirota H, Klinman DM (2010) Short- and long-term changes in gene expression mediated by the activation of TLR9. Mol Immunol 47:1317-1324. doi: 10.1016/j.molimm.2009.11.014
24. Klinman DM, Klaschik S, Sato T, Tross D (2009) CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases. Adv Drug Deliv Rev 61:248-255. doi: 10.1016/j.addr.2008.12.012
25. Knuefermann P, Schwederski M, Velten M, Krings P, Ehrentraut H, Rüdiger M, Boehm O, Fink K, Dreiner U, Grohe C, Hoeft A, Baumgarten G, Koch A, Zacharowski K, Meyer R (2008) Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of toll-like receptor 9. Cardiovasc Res 78:26-35. doi: 10.1093/cvr/cvn011 (Pubitemid 351430962)
26. Lips DJ, van der Nagel T, Steendijk P, Palmen M, Janssen BJ, van Dantzig JM, de Windt LJ, Doevendans PA (2004) Left ventricular pressure-volume measurements in mice: comparison of closed-chest versus open-chest approach. Basic Res Cardiol 99:351-359. doi: 10.1007/s00395-004-0476-5 (Pubitemid 39236725)
27. Matar F, Mroue J (2012) The management of thrombotic lesions in the cardiac catheterization laboratory. J Cardiovasc Transl Res 5:52-61. doi: 10.1007/s12265-011-9327-6
28. Mathur S, Walley KR, Boyd JH (2011) The Toll-like receptor 9 ligand CPG-C attenuates acute inflammatory cardiac dysfunction. Shock 36:478-483. doi: 10.1097/SHK.0b013e31822d6442
29. Mersmann J, Berkels R, Zacharowski P, Tran N, Koch A, Iekushi K, Dimmeler S, Granja TF, Boehm O, Claycomb WC, Zacharowski K (2010) Preconditioning by toll-like receptor 2 agonist Pam3CSK4 reduces CXCL1-dependent leukocyte recruitment in murine myocardial ischemia/reperfusion injury. Crit Care Med 38:903-909. doi: 10.1097/CCM.0b013e3181ce50e6
30. Meybohm P, Zacharowski K, Cremer J, Roesner J, Kletzin F, Schaelte G, Felzen M, Strouhal U, Reyher C, Heringlake M, Schon J, Brandes I, Bauer M, Knuefermann P, Wittmann M, Hachenberg T, Schilling T, Smul T, Maisch S, Sander M, Moormann T, Boening A, Weigand MA, Laufenberg R, Werner C, Winterhalter M, Treschan T, Stehr SN, Reinhart K, Hasenclever D, Brosteanu O, Bein B, Group RIPH-SI (2012) Remote ischaemic preconditioning for heart surgery. The study design for a multi-center randomized double-blinded controlled clinical trial - the RIPHeart-Study. Eur Heart J 33:1423-1426. doi: 10.1093/eurheartj/ehs131
31. Michelsen MM, Stottrup NB, Schmidt MR, Lofgren B, Jensen RV, Tropak M, St-Michel EJ, Redington AN, Botker HE (2012) Exercise-induced cardioprotection is mediated by a bloodborne, transferable factor. Basic Res Cardiol 107:260. doi: 10.1007/s00395-012-0260-x
32. Murad YM, Clay TM (2009) CpG oligodeoxynucleotides as TLR9 agonists: therapeutic applications in cancer. BioDrugs 23:361-375. doi: 10.2165/11316930-000000000-00000
33. Parajuli N, Yuan Y, Zheng X, Bedja D, Cai ZP (2012) Phosphatase PTEN is critically involved in post-myocardial infarction remodeling through the Akt/interleukin-10 signaling pathway. Basic Res Cardiol 107:248. doi: 10.1007/s00395-012-0248-6
34. Pedersen BK, Febbraio MA (2008) Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 88:1379-1406. doi: 10.1152/physrev.90100.2007
35. Riess ML, Stowe DF, Warltier DC (2004) Cardiac pharmacological preconditioning with volatile anesthetics: from bench to bedside? Am J Physiol 286:H1603-H1607. doi: 10.1152/ajpheart.00963.2003 (Pubitemid 38525444)
36. Schoenborn JR, Wilson CB (2007) Regulation of interferon-γ during innate and adaptive immune responses. Adv Immunol 96:41-101. doi: 10.1016/S0065-2776(07)96002-2 (Pubitemid 350018717)
37. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, Finnerty CC, Lopez CM, Honari S, Moore EE, Minei JP, Cuschieri J, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Jeschke MG, Klein MB, Gamelli RL, Gibran NS, Brownstein BH, Miller-Graziano C, Calvano SE, Mason PH, Cobb JP, Rahme LG, Lowry SF, Maier RV, Moldawer LL, Herndon DN, Davis RW, Xiao W, Tompkins RG, Host Response Inflammation to Injury LSCRP (2013) Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Nat Act Sci USA 110:3507-3512. doi: 10.1073/pnas.1222878110
38. Silverstein R (2004) D-galactosamine lethality model: scope and limitations. J Endotoxin Res 10:147-162. doi: 10.1179/096805104225004879 (Pubitemid 38877735)
39. Stapel H, Kim SC, Osterkamp S, Knuefermann P, Hoeft A, Meyer R, Grohe C, Baumgarten G (2006) Toll-like receptor 4 modulates myocardial ischaemia-reperfusion injury: role of matrix metalloproteinases. Eur J Heart Fail 8:665-672. doi: 10.1016/j.ejheart.2006.03.005 (Pubitemid 44635319)
40. Stevens SL, Leung PY, Vartanian KB, Gopalan B, Yang T, Simon RP, Stenzel-Poore MP (2011) Multiple preconditioning paradigms converge on interferon regulatory factor-dependent signaling to promote tolerance to ischemic brain injury. J Neurosci 31:8456-8463. doi: 10.1523/JNEUROSCI.0821-11. 2011
41. Stunz LL, Lenert P, Peckham D, Yi AK, Haxhinasto S, Chang M, Krieg AM, Ashman RF (2002) Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells. Eur J Immunol 32:1212-1222. doi: 10.1002/1521-4141(200205)32:5<1212:AID-IMMU1212>3.0.CO;2-D (Pubitemid 34546248)
42. Tittel AP, Heuser C, Ohliger C, Knolle PA, Engel DR, Kurts C (2011) Kidney dendritic cells induce innate immunity against bacterial pyelonephritis. J Am Soc Nephrol 22:1435-1441. doi: 10.1681/ASN.2010101072
43. Ueda Y, Kondo M, Kelsoe G (2005) Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J Exp Med 201:1771-1780. doi: 10.1084/jem.20041419 (Pubitemid 41002896)
44. Velten M, Duerr GD, Pessies T, Schild J, Lohner R, Mersmann J, Dewald O, Zacharowski K, Klaschik S, Hilbert T, Hoeft A, Baumgarten G, Meyer R, Boehm O, Knuefermann P (2012) Priming with synthetic oligonucleotides attenuates pressure overload-induced inflammation and cardiac hypertrophy in mice. Cardiovasc Res 96:422-432. doi: 10.1093/cvr/cvs280
45. Wang E, Feng Y, Zhang M, Zou L, Li Y, Buys ES, Huang P, Brouckaert P, Chao W (2011) Toll-like receptor 4 signaling confers cardiac protection against ischemic injury via inducible nitric oxide synthase- and soluble guanylate cyclase-dependent mechanisms. Anesthesiology 114:603-613. doi: 10.1097/ALN.0b013e31820a4d5b
46. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, Speed TP (2002) Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 30:e15. doi: 10.1093/nar/30.4.e15
47. Yu M, Wang H, Ding A, Golenbock DT, Latz E, Czura CJ, Fenton MJ, Tracey KJ, Yang H (2006) HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 26:174-179. doi: 10.1097/01.shk.0000225404.51320.82 (Pubitemid 44162504)
48. Zia A, Kern KB (2011) Management of postcardiac arrest myocardial dysfunction. Curr Opin Crit Care 17:241-246. doi: 10.1097/MCC.0b013e3283447759